119 related articles for article (PubMed ID: 8284003)
1. The bone density of female twins discordant for tobacco use.
Hopper JL; Seeman E
N Engl J Med; 1994 Feb; 330(6):387-92. PubMed ID: 8284003
[TBL] [Abstract][Full Text] [Related]
2. Determinants of bone density in 30- to 65-year-old women: a co-twin study.
MacInnis RJ; Cassar C; Nowson CA; Paton LM; Flicker L; Hopper JL; Larkins RG; Wark JD
J Bone Miner Res; 2003 Sep; 18(9):1650-6. PubMed ID: 12968674
[TBL] [Abstract][Full Text] [Related]
3. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
4. Calcium supplementation and increases in bone mineral density in children.
Johnston CC; Miller JZ; Slemenda CW; Reister TK; Hui S; Christian JC; Peacock M
N Engl J Med; 1992 Jul; 327(2):82-7. PubMed ID: 1603140
[TBL] [Abstract][Full Text] [Related]
5. A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis.
Sinigaglia L; Nervetti A; Mela Q; Bianchi G; Del Puente A; Di Munno O; Frediani B; Cantatore F; Pellerito R; Bartolone S; La Montagna G; Adami S
J Rheumatol; 2000 Nov; 27(11):2582-9. PubMed ID: 11093437
[TBL] [Abstract][Full Text] [Related]
6. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
Neer RM; Arnaud CD; Zanchetta JR; Prince R; Gaich GA; Reginster JY; Hodsman AB; Eriksen EF; Ish-Shalom S; Genant HK; Wang O; Mitlak BH
N Engl J Med; 2001 May; 344(19):1434-41. PubMed ID: 11346808
[TBL] [Abstract][Full Text] [Related]
7. The effect of postmenopausal estrogen therapy on bone density in elderly women.
Felson DT; Zhang Y; Hannan MT; Kiel DP; Wilson PW; Anderson JJ
N Engl J Med; 1993 Oct; 329(16):1141-6. PubMed ID: 8377776
[TBL] [Abstract][Full Text] [Related]
8. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.
Liberman UA; Weiss SR; Bröll J; Minne HW; Quan H; Bell NH; Rodriguez-Portales J; Downs RW; Dequeker J; Favus M
N Engl J Med; 1995 Nov; 333(22):1437-43. PubMed ID: 7477143
[TBL] [Abstract][Full Text] [Related]
9. [Bone mineral density in postmenopausal women with proximal femoral fractures--comparative study between quantitative ultrasonometry and gold standard DXA].
Schnabel M; Eser G; Ziller V; Mann D; Mann E; Hadji P
Zentralbl Chir; 2005 Oct; 130(5):469-75. PubMed ID: 16220445
[TBL] [Abstract][Full Text] [Related]
10. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women.
Dawson-Hughes B; Dallal GE; Krall EA; Sadowski L; Sahyoun N; Tannenbaum S
N Engl J Med; 1990 Sep; 323(13):878-83. PubMed ID: 2203964
[TBL] [Abstract][Full Text] [Related]
11. Reduced femoral neck bone density in the daughters of women with hip fractures: the role of low peak bone density in the pathogenesis of osteoporosis.
Seeman E; Tsalamandris C; Formica C; Hopper JL; McKay J
J Bone Miner Res; 1994 May; 9(5):739-43. PubMed ID: 8053404
[TBL] [Abstract][Full Text] [Related]
12. Effect of calcium supplementation on bone loss in postmenopausal women.
Reid IR; Ames RW; Evans MC; Gamble GD; Sharpe SJ
N Engl J Med; 1993 Feb; 328(7):460-4. PubMed ID: 8421475
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and risk factors of osteoporosis in Korea: a community-based cohort study with lumbar spine and hip bone mineral density.
Shin CS; Choi HJ; Kim MJ; Kim JT; Yu SH; Koo BK; Cho HY; Cho SW; Kim SW; Park YJ; Jang HC; Kim SY; Cho NH
Bone; 2010 Aug; 47(2):378-87. PubMed ID: 20362081
[TBL] [Abstract][Full Text] [Related]
14. Determinants of bone mass in 10- to 26-year-old females: a twin study.
Young D; Hopper JL; Nowson CA; Green RM; Sherwin AJ; Kaymakci B; Smid M; Guest CS; Larkins RG; Wark JD
J Bone Miner Res; 1995 Apr; 10(4):558-67. PubMed ID: 7610926
[TBL] [Abstract][Full Text] [Related]
15. Smoking and bone loss among postmenopausal women.
Krall EA; Dawson-Hughes B
J Bone Miner Res; 1991 Apr; 6(4):331-8. PubMed ID: 1858519
[TBL] [Abstract][Full Text] [Related]
16. Skeletal effects of raloxifene after 8 years: results from the continuing outcomes relevant to Evista (CORE) study.
Siris ES; Harris ST; Eastell R; Zanchetta JR; Goemaere S; Diez-Perez A; Stock JL; Song J; Qu Y; Kulkarni PM; Siddhanti SR; Wong M; Cummings SR;
J Bone Miner Res; 2005 Sep; 20(9):1514-24. PubMed ID: 16059623
[TBL] [Abstract][Full Text] [Related]
17. Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: results of a randomized controlled clinical trial.
Lane NE; Sanchez S; Modin GW; Genant HK; Pierini E; Arnaud CD
J Bone Miner Res; 2000 May; 15(5):944-51. PubMed ID: 10804025
[TBL] [Abstract][Full Text] [Related]
18. Bone mineral density in rural Thai adults living in Khon Kaen province.
Pongchaiyakul C; Rojroongwasinkul N; Chotmongkol R; Kosulwat V; Charoenkiatkul S; Rajatanavin R
J Med Assoc Thai; 2002 Feb; 85(2):235-44. PubMed ID: 12081125
[TBL] [Abstract][Full Text] [Related]
19. Bone mineral density in healthy Dutch women: spine and hip measurements using dual-energy X-ray absorptiometry.
Erdtsieck RJ; Pols HA; Algra D; Kooy PP; Birkenhäger JC
Neth J Med; 1994 Nov; 45(5):198-205. PubMed ID: 7830845
[TBL] [Abstract][Full Text] [Related]
20. Osteoporosis in anorexia nervosa: the influence of peak bone density, bone loss, oral contraceptive use, and exercise.
Seeman E; Szmukler GI; Formica C; Tsalamandris C; Mestrovic R
J Bone Miner Res; 1992 Dec; 7(12):1467-74. PubMed ID: 1481732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
